Clinical Trials Directory

Trials / Conditions / Myositis

Myositis

51 registered clinical trials studyying Myositis10 currently recruiting.

StatusTrialSponsorPhase
WithdrawnStudy of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis
NCT07012057
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Phase 2
RecruitingAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Ritux
NCT06991114
Artiva Biotherapeutics, Inc.Phase 2
RecruitingMIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
NCT07374107
Myositis International Health & Research Collaborative Alliance Foundation
RecruitingMuscle Health Measurements Using Electrical Impedance Myography
NCT07502989
Beth Israel Deaconess Medical Center
RecruitingA Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
NCT06925542
CRISPR TherapeuticsPhase 1
CompletedMultispectral Optoacustic Imaging in Patients With Myositis
NCT06966739
University of Giessen
Not Yet RecruitingNeuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature
NCT06740656
Central Hospital, Nancy, France
Active Not RecruitingA Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
NCT06284954
argenxPhase 2
RecruitingInvestigation of the Validity, Reliability, and Responsiveness of the BETY-BQ in Myositis
NCT06587724
Hacettepe University
Enrolling By InvitationA Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults Wi
NCT05979441
argenxPhase 3
UnknownCharacterizing Myositis With 68Ga-FAPI PET/CT
NCT05952531
The First Affiliated Hospital of Xiamen UniversityEARLY_Phase 1
WithdrawnRheumatoid Arthritis and Myositis Cohort
NCT05627089
Attune Health Research, Inc.
RecruitingA Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory
NCT05895786
PfizerPhase 3
UnknownMagnetic Resonance Imaging and Ultrasonography in Evaluation of Muscle Diseases
NCT05692349
Assiut University
Active Not RecruitingA Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiop
NCT05523167
argenxPhase 2 / Phase 3
CompletedEffectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being
NCT06300983
Hospital Universitari Vall d'Hebron Research InstituteN/A
Active Not RecruitingA Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
NCT05379634
Janssen Research & Development, LLCPhase 2
RecruitingClinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT05251415
University Hospital, Toulouse
Active Not RecruitingAdd-on Intravenous Immunoglobulins in Early Myositis
NCT05832034
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 2 / Phase 3
CompletedHigh-intensity Strength Training in Myositis
NCT04486261
Rigshospitalet, DenmarkN/A
TerminatedComparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations
NCT04309227
Louisiana State University Health Sciences Center ShreveportN/A
UnknownProspective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement
NCT04367350
University Hospital Tuebingen
UnknownPredictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit
NCT04022655
University of Göttingen
TerminatedNovel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions
NCT03912428
National Institute of Mental Health (NIMH)Phase 1
TerminatedSmartphone Mindfulness Meditation for Patients With Rheumatic Diseases
NCT03937856
Johns Hopkins UniversityN/A
CompletedFeasibility of a Blended Therapy Approach
NCT03713151
University of ZurichN/A
CompletedStudy of Pioglitazone in Sporadic Inclusion Body Myositis
NCT03440034
Johns Hopkins UniversityPhase 1
CompletedImmune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction
NCT03492242
Groupe Hospitalier Pitie-Salpetriere
CompletedAbatacept for the Treatment of Myositis-associated Interstitial Lung Disease
NCT03215927
Rohit Aggarwal, MDPhase 2
CompletedPredictor of Clinical Response to Acthar in Myositis
NCT03414086
University of Pittsburgh
Active Not RecruitingMYOPROSP - a Prospective Cohort Study in Myositis
NCT02468895
University of Manchester
CompletedPhenomics in Autoimmune and Inflammatory Diseases
NCT02466217
Assistance Publique - Hôpitaux de Paris
WithdrawnPregnancy and Medically Assisted Conception in Rare Diseases
NCT02450396
Assistance Publique - Hôpitaux de Paris
UnknownPatientSpot Formerly Known as ArthritisPower
NCT03840928
Global Healthy Living Foundation
CompletedBelimumab in Idiopathic Inflammatory Myositis
NCT02347891
Northwell HealthPhase 2 / Phase 3
CompletedEnvironmental Risk Factors for Myositis in Military Personnel
NCT01734369
National Institute of Environmental Health Sciences (NIEHS)
CompletedValidation of Rehab Assessments in Myositis Patients
NCT03059394
University of Zurich
CompletedKinesio Taping Effects Applied With Different Directions and Tensions
NCT02501915
Universidade Estadual de GoiásPhase 1
CompletedAt-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurolo
NCT01931644
Sanguine Biosciences
CompletedUltrasound in Muscle Biopsy
NCT01790178
Duke UniversityN/A
UnknownDiagnostic Accuracy of MR in Myositis
NCT01702870
University of Warwick
UnknownExercise in Sjogren, Myositis and Takayasu's Arteritis
NCT01501019
University of Sao PauloN/A
RecruitingEnvironmental Risk Factors for the Anti-synthetase Syndrome
NCT01276470
National Institute of Environmental Health Sciences (NIEHS)
CompletedDiagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
NCT01432613
Assistance Publique - Hôpitaux de ParisN/A
UnknownPhysical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation
NCT01184625
Karolinska InstitutetN/A
CompletedRituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
NCT00774462
Assistance Publique - Hôpitaux de ParisPhase 2
CompletedRituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
NCT00106184
University of PittsburghPhase 2
CompletedResistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositi
NCT00519103
Karolinska InstitutetN/A
CompletedImmune Abnormalities in Sporadic Inclusion Body Myositis
NCT00030212
National Institute of Neurological Disorders and Stroke (NINDS)
Active Not RecruitingInvestigating Genes in Patients With Polymyositis and Dermatomyositis
NCT01171573
Northern Care Alliance NHS Foundation Trust
CompletedGenetic and Family Studies of Inherited Muscle Diseases
NCT00001331
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)